Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

January 15, 2022; Volume 19,Issue 1

Editorial

  • You have access
    Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
    Ning Zhang and Xishan Hao
    Cancer Biology & Medicine January 2022, 19 (1) 1-3; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0514

Review

  • You have access
    Molecular testing for acute myeloid leukemia
    Dahui Qin
    Cancer Biology & Medicine January 2022, 19 (1) 4-13; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0734
  • You have access
    The biogenesis, function and clinical significance of circular RNAs in breast cancer
    Yan Zeng, Yutian Zou, Guanfeng Gao, Shaoquan Zheng, Song Wu, Xiaoming Xie and Hailin Tang
    Cancer Biology & Medicine January 2022, 19 (1) 14-29; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0485
  • You have access
    Examining heterogeneity of stromal cells in tumor microenvironment based on pan-cancer single-cell RNA sequencing data
    Wenhui Wang, Li Wang, Junjun She and Jun Zhu
    Cancer Biology & Medicine January 2022, 19 (1) 30-42; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0762
  • You have access
    Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy
    Jiali Dong, Yuan Li, Huiwen Xiao, Ming Cui and Saijun Fan
    Cancer Biology & Medicine January 2022, 19 (1) 43-55; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0476

Original Article

  • You have access
    Single-cell trajectories of melanoma cell resistance to targeted treatment
    Maria Schmidt, Lena Sünke Mortensen, Henry Loeffler-Wirth, Corinna Kosnopfel, Knut Krohn, Hans Binder and Manfred Kunz
    Cancer Biology & Medicine January 2022, 19 (1) 56-73; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0267
  • You have access
    Drug repurposing for cancer treatment through global propagation with a greedy algorithm in a multilayer network
    Xi Cheng, Wensi Zhao, Mengdi Zhu, Bo Wang, Xuege Wang, Xiaoyun Yang, Yuqi Huang, Minjia Tan and Jing Li
    Cancer Biology & Medicine January 2022, 19 (1) 74-89; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0218
  • You have access
    Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway
    Mingyan He, Jing Hu, Tingting Fang, Wenqing Tang, Bei Lv, Biwei Yang and Jinglin Xia
    Cancer Biology & Medicine January 2022, 19 (1) 90-103; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0313
  • You have access
    SNORA23 inhibits HCC tumorigenesis by impairing the 2′-O-ribose methylation level of 28S rRNA
    Zhiyong Liu, Yanan Pang, Yin Jia, Qin Qin, Rui Wang, Wei Li, Jie Jing, Haidong Liu and Shanrong Liu
    Cancer Biology & Medicine January 2022, 19 (1) 104-119; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0343
  • You have access
    CUL4B facilitates HBV replication by promoting HBx stabilization
    Haixia Shan, Bo Wang, Xiaodong Zhang, Hui Song, Xi Li, Yongxin Zou, Baichun Jiang, Huili Hu, Hao Dou, Changshun Shao, Lifen Gao, Chunhong Ma, Xiaoyun Yang, Xiaohong Liang and Yaoqin Gong
    Cancer Biology & Medicine January 2022, 19 (1) 120-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0468
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (1)
Cancer Biology & Medicine
Vol. 19, Issue 1
15 Jan 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire